| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 9872560 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 9 Pages | 
Abstract
												Conclusion: V30 and MLD can be used to predict the risk of RP in lung cancer patients undergoing radical radiotherapy.
											Related Topics
												
													Physical Sciences and Engineering
													Physics and Astronomy
													Radiation
												
											Authors
												Michael (F.R.A.C.P., F.R.A.N.Z.C.R.), Alex M.B., B.S., Richard M.B., B.S., Ph.D., Michael (F.R.C.R., F.R.A.N.Z.C.R.), Andrew (F.R.A.C.P., F.R.A.N.Z.C.R.), David (F.R.A.N.Z.C.R.), 
											